Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis

NCT06414512 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT06414512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
April 9, 2024
Completion date
October 2, 2024
Enrollment
48 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cryptococcal meningitis